Shanghai Weimu Medical Technology Co., Ltd. announced that it has raised over CNY 100 million in a round of funding co-led by new investors, Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd. on December 6, 2023. The transaction included participation from new investors, SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, and returning investors, Jiaxing Woyong Investment Partnership Enterprise (LP) a fund managed by Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.